Myd88 ablation alleviates MPN disease burden. (A) Schematic of TLR-mediated NF-κB signaling cascade. (B) Schematic of the Myd88−/−MPLW515L mouse model. (C) WBC counts of MPL (n = 8) and MPL-Myd88−/− (n = 8) mice. Statistics were assessed by 2-way ANOVA. Light gray regions indicate the normal reference range. (D) Monocyte, BM CD45.2 myeloid cells, hematocrit, and platelet counts at end point (MPL [n = 8], MPL-Myd88−/− [n = 7]). Statistics were assessed by 2-tailed Student t test. (E) Normalized spleen weight at end point. Statistics were assessed by 2-tailed Student t test. (F) Percentage of HSCs of BM cells. (G) Distribution of hematopoietic progenitor populations at end point. Statistics were assessed by 2-tailed Student t test. (H) Kaplan-Meier survival curve. Statistics were assessed by log-rank test. (I) Histology of the spleen and BM at end point. Scale bar = 75 μm. Histology of the spleen and BM at end point. Scale bar = 75 μm. BM fibrosis was scored from 3 mice in each group.